• Become A Member
  • Gift Membership
  • Gift Membership
Scroll.in Logo
  • Gift Membership
  • Sign In
  • Become A Member
  • Home
  • Common Ground
  • The Latest
  • Members-Only
  • Video
  • Eco India
  • The Reel
  • Magazine
  • Trending
    Trending
    • ‘Chrislam’: In Nigeria, why two religions are better than one

      ‘Chrislam’: In Nigeria, why two religions are better than one

      Marloes Janson, The Conversation
    • In Ladakh, climate change is raining on apricots, central to life and the economy

      In Ladakh, climate change is raining on apricots, central to life and the economy

      Avidha Raha
    • The Indian Foreign Service built the country’s reputation. Now, it seeks awards for one leader

      The Indian Foreign Service built the country’s reputation. Now, it seeks awards for one leader

      Ashok Swain
    • Maharashtra sets up panel to examine if STs who convert to other faiths should get quota benefits

      Maharashtra sets up panel to examine if STs who convert to other faiths should get quota benefits

      Scroll Staff
    • Brand strategist Ambi Parameswaran reflects on the 1980-1990s, when ads focused on children

      Brand strategist Ambi Parameswaran reflects on the 1980-1990s, when ads focused on children

      Ambi Parameswaran
    • Why angry young protesters in Delhi have turned against Modi

      Why angry young protesters in Delhi have turned against Modi

      Anant Gupta
       & 
      Ayush Tiwari
    • Cockroach Janta Party protest: How liberal scepticism induces paralysis in oppositional politics

      Cockroach Janta Party protest: How liberal scepticism induces paralysis in oppositional politics

      Milind Murugkar
    • ‘Bol Bol Rani’ review: Sai Tamhankar prevents a mind game thriller from being a brain fade

      ‘Bol Bol Rani’ review: Sai Tamhankar prevents a mind game thriller from being a brain fade

      Nandini Ramnath
    • ‘This one line is my bible – every footnote is a confession of failure’: Translator Daisy Rockwell

      ‘This one line is my bible – every footnote is a confession of failure’: Translator Daisy Rockwell

      Chintan Girish Modi
    • From the memoir: When Oscar Wilde’s daughter-in-law did ‘Oriental’ makeup for Qurratulain Hyder

      From the memoir: When Oscar Wilde’s daughter-in-law did ‘Oriental’ makeup for Qurratulain Hyder

      Qurratulain Hyder
       & 
      Fatima Rizvi
    • Why tree cutting on Dehradun highway could upend the life of a community

      Why tree cutting on Dehradun highway could upend the life of a community

      Vaishnavi Rathore
    • ‘Fractured Communities’ by Umar Khalid: Scholarship meets commitment to marginalised lives

      ‘Fractured Communities’ by Umar Khalid: Scholarship meets commitment to marginalised lives

      Anand Teltumbde
    We Need Your Help
    Scroll has produced award-winning journalism despite threats, falling ad revenues and rising costs. Support our work. Become a member today.
  • More
    More
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Health
    • Education
    • Climate and Environment
    Newsletters
    • The Daily Brief
    • Now Watching By The Reel
    Read on the Go
    Get updates
    Please Don't Look Away
    AI is hollowing out independent media, stealing our readership and revenue. Only you can stop this bleeding. Support our work. Join Scroll today!
  • Newsletters

DCGI

  • Drug regulators stop production at 18 firms in drive against spurious medicines

    Drug regulators stop production at 18 firms in drive against spurious medicines

    Scroll Staff
    · Mar 28, 2023 · 08:26 pm
  • Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tabassum Barnagarwala
    · Feb 04, 2023 · 05:34 pm
  • Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Tabassum Barnagarwala
    · Feb 03, 2023 · 06:42 pm
  • India’s drug approval system is broken but a proposed new law does nothing to fix it

    India’s drug approval system is broken but a proposed new law does nothing to fix it

    Dinesh Thakur Prashant Reddy T
    · Aug 06, 2022 · 09:00 am
  • Serum Institute of India applies for full market authorisation of Covishield vaccine

    Serum Institute of India applies for full market authorisation of Covishield vaccine

    Scroll Staff
    · Dec 31, 2021 · 06:47 pm
  • Covaxin receives DCGI approval for use in children from 12 to 18 years

    Covaxin receives DCGI approval for use in children from 12 to 18 years

    Scroll Staff
    · Dec 26, 2021 · 08:15 am
  • Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Scroll Staff
    · Sep 03, 2021 · 09:34 pm
  • Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Scroll Staff
    · Jan 06, 2021 · 11:01 am
  • Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Scroll Staff
    · Jan 03, 2021 · 03:09 pm
  • Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Scroll Staff
    · Sep 16, 2020 · 10:35 am